EKF Diagnostics Presents Latest Diabetes Care Analyzers
|
By LabMedica International staff writers Posted on 31 Jan 2019 |

Image: The Lactate Scout 4 analyzer for athletes (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, Wales, UK) presented its latest diabetes care analyzers at MedLab Middle East, a leading laboratory and flagship exhibition and conference spanning across the Middle East, Asia and West Europe. MedLab Middle East 2019 provided an international platform for laboratory management and medicine to exhibit their products ranging from ayurvedic & herbal to medical & pharmaceutical essentials in medical research & development & scientific instruments. The Conference provided education, best practices and the chance to learn, meet and network with leading laboratorians from across the globe.
At MedLab Middle East, EKF Diagnostics displayed DiaSpect Tm, the world’s fastest hemoglobin analyzer that delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The hemoglobin analyzer is palm-sized, making it easily transportable, and ideal for use in any screening setting even in challenging climatic environments. EKF Diagnostics also exhibited the Quo-Lab HbA1c desktop point-of-care analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use.
Also on display at the event was EKF Diagnostics’ Quo-Test HbA1c system, a fully automated HbA1c analyzer that uses patented boronate affinity fluorescence quenching technology to measure HbA1c from a 4-μl sample taken from a finger prick or venous whole blood. It has been designed for easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting such as diabetes clinics and doctors’ surgeries. EKF Diagnostics’ also exhibited Hemo Control, its point-of-care hemoglobin analyzer designed to provide quantitative, lab quality hemoglobin results from 25 seconds. Hemo Control uses the most established photometric azide methemoglobin method, ensuring reliable results with a high precision (CV <2%).
Among the latest products displayed by EKF Diagnostics at MedLab Middle East was its new Lactate Scout 4 lactate analyzer for athletes. Lactate Scout 4 is used by sports medicine and sport professionals for the easy and reliable measurement of lactate while training on the track, working out in the gym or analyzing their performance in the laboratory. It has been ergonomically designed to be effectively used in the field as a training companion for coaches and athletes to determine optimum training programs, define training zones, and avoid inefficient training exercises. The hand-held lactate analyzer requires just 0.2 µl of capillary blood and returns results in 10 seconds. Up to 500 results can be stored on the Lactate Scout 4, which also features easy connection to heart rate monitors, stopwatch function to aid performance measurement, integrated step test function and Bluetooth connectivity.
At MedLab Middle East, EKF Diagnostics displayed DiaSpect Tm, the world’s fastest hemoglobin analyzer that delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The hemoglobin analyzer is palm-sized, making it easily transportable, and ideal for use in any screening setting even in challenging climatic environments. EKF Diagnostics also exhibited the Quo-Lab HbA1c desktop point-of-care analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use.
Also on display at the event was EKF Diagnostics’ Quo-Test HbA1c system, a fully automated HbA1c analyzer that uses patented boronate affinity fluorescence quenching technology to measure HbA1c from a 4-μl sample taken from a finger prick or venous whole blood. It has been designed for easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting such as diabetes clinics and doctors’ surgeries. EKF Diagnostics’ also exhibited Hemo Control, its point-of-care hemoglobin analyzer designed to provide quantitative, lab quality hemoglobin results from 25 seconds. Hemo Control uses the most established photometric azide methemoglobin method, ensuring reliable results with a high precision (CV <2%).
Among the latest products displayed by EKF Diagnostics at MedLab Middle East was its new Lactate Scout 4 lactate analyzer for athletes. Lactate Scout 4 is used by sports medicine and sport professionals for the easy and reliable measurement of lactate while training on the track, working out in the gym or analyzing their performance in the laboratory. It has been ergonomically designed to be effectively used in the field as a training companion for coaches and athletes to determine optimum training programs, define training zones, and avoid inefficient training exercises. The hand-held lactate analyzer requires just 0.2 µl of capillary blood and returns results in 10 seconds. Up to 500 results can be stored on the Lactate Scout 4, which also features easy connection to heart rate monitors, stopwatch function to aid performance measurement, integrated step test function and Bluetooth connectivity.
Latest MEDLAB 2019 News
- ERBA Group Launches New Hematology Analyzers at MEDLAB 2019
- Telstar Promotes Latest Generation of Freeze Dryers in Dubai
- Siemens Healthineers Showcases In-Vitro Diagnostics Products at MedLab 2019
- Randox Promotes Evidence MultiSTAT Automated Benchtop Immunoassay Analyzer
- Mindray Displays New Generation Benchtop Cellular Analysis Line
- HORIBA Medical Shows Latest Yumizen G Range at Lab Trade Show
- Greiner Bio-One Displays Range of Safety Products at MedLab
- BioSystems Highlights New iFOB Integral System at MedLab 2019
- Beckman Coulter Exhibits New Hematology Analyzer in Middle East
- Agappe Diagnostics Displays Analyzers and Solutions at Middle East Congress
- Abbott Highlights Point of Care Management Solutions
Channels
Clinical Chemistry
view channel
New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed at an advanced stage and remains one of the most lethal solid tumors. Clinicians commonly use serum carbohydrate antigen 19-9 (CA19-9) to... Read more
Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
Psychosis commonly emerges in adolescence or early adulthood and can severely disrupt social and occupational functioning. Hallucinations, delusions, and disorganized thinking often evolve gradually, hindering... Read moreMolecular Diagnostics
view channel
New RNA Origami Method Supports Faster Targeted Testing for Repeat Expansion Disorders
Repeat expansion disorders drive conditions such as myotonic dystrophy, Huntington’s disease, and amyotrophic lateral sclerosis (ALS), yet accurately sizing the mutated sequences remains difficult.... Read more
FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling
Timely, comprehensive tumor profiling helps clinicians make treatment selection decisions for patients with advanced cancer. Blood-based approaches can provide actionable insights from a simple draw and... Read moreHematology
view channel
Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
Iron deficiency in school-age children can affect brain development, learning, growth, and physical performance, yet early deficiency may be missed when screening focuses mainly on anemia.... Read more
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read moreImmunology
view channel
Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read more
Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitoring
Lung transplant recipients face some of the highest rates of acute cellular rejection, and routine surveillance often relies on repeated surgical biopsies. These procedures can cause complications such... Read moreMicrobiology
view channel
New AMR Assay Supports Rapid Infection Control Screening in Hospitals
As antimicrobial resistance spreads worldwide, healthcare-associated infections are placing a growing burden on hospitals, increasing the need for faster and broader diagnostic solutions.... Read more
Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
In eastern Democratic Republic of the Congo, communities are confronting a resurgence of Bundibugyo ebolavirus, a rarer species for which no vaccines or treatments have been approved. Ebola is a highly... Read more
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read morePathology
view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
Non–muscle invasive bladder cancer has highly variable outcomes, complicating surveillance and treatment planning. Risk assessment typically relies on stage, grade, and tumor size, leaving uncertainty... Read moreTechnology
view channel
AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
Clinical laboratories and research groups face increasingly complex molecular workflows and expanding technical documentation spread across multiple systems. Fragmented digital tools can slow experiment... Read more
AI Tool Automates Validation of Laboratory Software Configuration Changes
Regulated laboratories face heavy documentation and requalification demands when software configurations change, slowing improvements and discouraging beneficial updates. A new capability now automates... Read moreIndustry
view channel
Strategic Collaboration Advances RNA Foundation Models for Precision Oncology
Bulk RNA sequencing is increasingly used to study tumor biology, but standard analyses often reduce results to gene-level summaries that miss important transcript variants and mutation patterns.... Read more









